REBISMART, the first electronic
injection device for the treatment
of multiple sclerosis, has been
approved for use in Australia and
will be available on the
Pharmaceutical Benefits Scheme
from 01 May.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Apr 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Apr 10
A UK campaign encouraging people to make pharmacy their first point of call for healthcare has kept almost 14,000 people out of hospitals over a three month period, Britain’s minister for the pharmacy sector has claimed.